What medication is appropriate for treating hematochezia?

Medication for Hematochezia

For acute hematochezia, initiate vasoactive drugs (octreotide, somatostatin, or terlipressin) immediately if variceal bleeding is suspected in cirrhotic patients, combined with antibiotic prophylaxis (ceftriaxone 1g IV daily), while most non-variceal lower GI bleeding requires supportive care with restrictive transfusion strategy rather than specific pharmacotherapy. 1, 2, 1

Variceal Bleeding (Portal Hypertension Context)

Immediate Pharmacological Therapy

When hematochezia occurs in patients with known or suspected cirrhosis and portal hypertension, vasoactive drug therapy must be started immediately—even before endoscopic confirmation of variceal source: 1

• Octreotide: 50 mcg IV bolus (can repeat in first hour if ongoing bleeding), followed by continuous infusion of 50 mcg/h for 3-5 days 2, 3, 1
• Somatostatin: 250 mcg IV bolus, followed by continuous infusion of 250 mcg/h (can increase to 500 mcg/h) 1
• Terlipressin: 2 mg IV every 4 hours for first 48 hours, then 1 mg every 4 hours thereafter 1

These agents reduce splanchnic blood flow and portal pressure, with proven efficacy in controlling bleeding and preventing early rebleeding. 2, 1

Mandatory Antibiotic Prophylaxis

All cirrhotic patients with GI bleeding require short-term antibiotic prophylaxis (maximum 7 days), as this reduces infections, rebleeding, and mortality: 2

• First-line: Ceftriaxone 1g IV every 24 hours (preferred in advanced cirrhosis or centers with quinolone-resistant organisms) 2
• Alternative: Norfloxacin 400 mg PO twice daily or IV ciprofloxacin if oral administration not possible 2

Bacterial infections occur in >50% of cirrhotic patients with GI bleeding and independently predict failure to control bleeding and death. 1

Anorectal Varices

For bleeding anorectal varices specifically: 4

• Vasoactive drugs (terlipressin or octreotide) should be considered to reduce splanchnic blood flow 4
• Prophylactic antibiotics are strongly recommended (short course) 4
• Temporarily suspend beta-blockers during acute bleeding if patient is hypotensive 4

Non-Variceal Lower GI Bleeding

Supportive Care Focus

For non-variceal hematochezia (diverticular bleeding, angiodysplasia, ischemic colitis, etc.), there are no specific pharmacological agents proven to stop bleeding—management centers on resuscitation and endoscopic/radiologic intervention: 5, 6

Transfusion Strategy

Restrictive transfusion thresholds are recommended: 1, 6

• Hemoglobin trigger: 7 g/dL with target of 7-9 g/dL after transfusion 1
• Exception: Patients with cardiovascular disease should have trigger of 8 g/dL and target of 10 g/dL 6

This restrictive approach improves outcomes compared to liberal transfusion strategies. 1

Anticoagulation Management

Warfarin should be interrupted at presentation for unstable bleeding and reversed with prothrombin complex concentrate plus vitamin K if severe. 6 For patients with high thrombotic risk (mechanical mitral valve, recent VTE <3 months), consider low molecular weight heparin bridging at 48 hours after hemostasis. 6

Critical Pitfalls to Avoid

• Do not delay vasoactive drugs in suspected variceal bleeding while waiting for endoscopy—up to 30% of cirrhotic patients bleed from non-variceal causes, but empiric therapy is still indicated 1
• Avoid over-transfusion: Liberal transfusion strategies worsen hepatic venous pressure gradient and increase mortality in variceal bleeding 1
• Do not use proton pump inhibitors as primary therapy for lower GI bleeding—they have no proven benefit except potentially reducing post-endoscopic band ligation ulcer size 2
• Erythromycin (250 mg IV 30-120 minutes before endoscopy) should be considered to improve visualization, but check QT interval first 1

Resuscitation Priorities

Regardless of etiology: 1, 3, 1

• Volume replacement with crystalloids (or colloids) to restore hemodynamic stability 1
• Maintain mean arterial pressure >65 mmHg but avoid fluid overload 4
• Ensure adequate airway protection: Intubate for active hematemesis, inability to protect airway, or to optimize endoscopy conditions 3
• Early endoscopy within 12 hours after stabilization to identify source and provide therapy 1, 2, 1